Inventiva S.A (IVA) | Stock Overview & Key Data
Inventiva S.A. | Mid-cap | Healthcare
Inventiva S.A. | Mid-cap | Healthcare
Inventiva S.A Performance Comparison
Stock Range
Today's Range
Low: €2.84
High: €2.93
on August 8, 2025
52 Week Range
Low: €1.43
High: €3.30
on October 8, 2024
on May 5, 2025
All-Time High: €16.30 on January 18, 2021
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€391.5M
EPS
-3.08
P/E Ratio (TTM)
-0.91
Forward P/E
-2.01
P/B Ratio
-1.02
PEG Ratio
-2.01
Div. Yield
N/A
ROE
172.73%
Beta
0.620
Debt to Equity
-1.70
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-384.43%
Profit Margin
0.00%
Returns and Earnings
Return on Assets (TTM)
-63.60%
Return on Equity (TTM)
172.73%
EBITDA
€-93.8M
Net Income (TTM)
€-184.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€0.15
Quarterly Revenue Growth (YoY)
-29.90%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Inventiva S.A IVA | 391.52M Mid-cap | 0.70% | 8.71% | -10.87% | 23.18% | 36.02% | 32.41% | -46.04% | -71.29% |
| Abivax SA ABVX | 4.49B Large-cap | -5.31% | 791.18% | 913.38% | 961.30% | 732.42% | 474.95% | 572.59% | 214.97% |
| Valneva SE VLA | 546.93M Mid-cap | 9.79% | 50.21% | 22.53% | 14.70% | 55.41% | 11.58% | -65.68% | -34.65% |
| Medincell S.A MEDCL | 524.62M Mid-cap | -6.41% | -1.79% | 2.65% | 0.70% | -9.29% | -0.06% | 197.92% | 112.23% |
| BNP Paribas Easy BLUE | 463.10M Mid-cap | -2.20% | -0.89% | 0.52% | -5.19% | -5.19% | -2.63% | 1.50% | 49.76% |
| Nanobiotix NANO | 283.01M Mid-cap | -1.63% | 44.95% | 97.06% | 55.81% | 96.42% | 35.01% | 44.96% | -15.35% |
Ownership & Short Interest
Insider Ownership
8.26%
Institutional Ownership
63.40%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
127K
Average 90-Day Volume
61K
Inventiva S.A Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Inventiva S.A would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is IVA's 52-week high and low?
- In the last 52 weeks, Inventiva S.A reached a high of €3.30 (on May 5, 2025) and a low of €1.43 (on October 8, 2024).
- What is the market cap and P/E ratio for IVA?
- Curious about Inventiva S.A's size and valuation? Its market capitalization stands at 391.52M. When it comes to valuation, the P/E ratio (trailing twelve months) is -0.91, and the forward P/E (looking ahead) is -2.01.
- Does IVA pay dividends? If so, what's the yield?
- As for dividends, Inventiva S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Inventiva S.A's main competitors or similar companies to consider before investing?
When looking at Inventiva S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abivax SA
ABVX4.49B Healthcare Biotechnology 474.95% 572.59% Valneva SE
VLA546.93M Healthcare Biotechnology 11.58% -65.68% Medincell S.A
MEDCL524.62M Healthcare Biotechnology -0.06% 197.92% BNP Paribas Easy
BLUE463.10M Healthcare Biotechnology -2.63% 1.50% Nanobiotix
NANO283.01M Healthcare Biotechnology 35.01% 44.96% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Inventiva S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Inventiva S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 172.73%, the Debt to Equity ratio from the most recent quarter is -1.70, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for IVA?
- Looking at Inventiva S.A's growth, its revenue over the trailing twelve months (TTM) was €14M. Compared to the same quarter last year (YoY), quarterly revenue grew by -29.90%, and quarterly earnings saw a YoY growth of N/A.
- How much of IVA stock is held by insiders and institutions?
- Wondering who owns Inventiva S.A stock? Company insiders (like executives and directors) hold about 8.26% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 63.40%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.